Eminyakeni yakamuva, imboni yasekhaya ye-in vitro diagnosis (IVD) ikhule ngokushesha.Ngokusho kwedatha ekhishwe yi-Evaluate MedTech, kusukela ngo-2014 kuya ku-2017, izinga lokuthengiswa kwemakethe yomhlaba wonke yemboni ye-IVD liye lenyuka unyaka nonyaka, lisuka ku-$49 billion 900 million ngo-2014 laya ku-$52 billion 600 million ngo-2017, ngesilinganiso sokukhula esiyinhlanganisela yonyaka 1.8%;ngo-2024, isilinganiso sokuthengisa emakethe kulindeleke ukuthi sifinyelele ku-$ 79 billion 600 million, kusukela ngo-2017 kuya ku-2024 Izinga lokukhula lonyaka elihlanganisiwe lifinyelele ku-6.1%.Kulo mongo, izidingo zomtholampilo ezikhulayo kanye namazinga okusebenza embonini nakho kubeka phambili izidingo ezintsha zemikhiqizo nobuchwepheshe be-IVD.Ngemva kweminyaka eyishumi yokuthuthukiswa okuzimele kwe-"Lica light-induced chemiluminescence technology", njengendlela entsha ye-chemiluminescent immunoassay, ukuxilongwa kwe-Kemei ngobuciko kusebenzisa uhlelo lokusabela olufanayo kanye nezinhlayiya ze-nano zobuchwepheshe obuphezulu, okuhlinzeka ngesixazululo esisha kumalabhorethri amaningi emitholampilo.Ngokusho kwedatha yomphakathi, emkhakheni we-chemiluminescence immunodiagnosis e-China, imiphumela emihle yendawo iye yafinyelelwa emkhakheni we-immunodiagnosis ophakathi nendawo ophansi.Kodwa-ke, emakethe ye-chemiluminescence ephezulu yaseShayina, abakhiqizi abangenisiwe basathatha ngaphezu kuka-80% wesabelo semakethe.Phakathi kwabo, u-Abbott, uRoche, u-Beckman no-Siemens benza cishe u-70% wesabelo semakethe.Kodwa-ke, ngokuthuthuka kwezinga lokusetshenziswa kwezokwelapha e-China, ukugqugquzelwa kwezinguquko zesistimu yezokwelapha, kanye nokwesekwa okuqinile kwezinqubomgomo zikazwelonke zezimboni, besigxile ekuthuthukisweni kwama-reagents atholakala e-in vitro, futhi sithemba ukubambisana nawe.